SUBSTITUTED 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRIDINE-3(2H)-ONES AND 2,5,6,7-TETRAHYDRO-3H-PYRROLO[2,1-C][1,2,4]TRIAZOL-3-ONES, AND USE THEREOF

The present application relates to new substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-c][1,2,4]triazol-3-ones, to methods for the synthesis thereof, the use thereof alone or in combination for the treatment and/or prophylaxis of diseases...

Full description

Saved in:
Bibliographic Details
Main Authors MEDING, JORG, NEUBAUER, THOMAS, TIMMERMANN, ANDREAS, BADOCK, VOLKER, BROCKSCHNIEDER, DAMIAN, MOORE, STEPHEN, SCHULZ, ALEXANDER, BIBER, NICOLE, MEIER, HEINRICH, MOOSMAYER, DIETER, MIYATAKE ONDOZABAL, HIDEKI, GERICKE, KERSTEN MATTHIAS, ZUBOV, DMITRY, LINDNER, NIELS, KOLLING, FLORIAN, SCHAFER, MARTINA, LUSTIG, KLEMENS, TERJUNG, CARSTEN
Format Patent
LanguageEnglish
French
Published 16.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present application relates to new substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-c][1,2,4]triazol-3-ones, to methods for the synthesis thereof, the use thereof alone or in combination for the treatment and/or prophylaxis of diseases, and the use thereof for manufacturing medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prophylaxis of inflammatory pulmonary diseases. La présente invention concerne de nouvelles 5,6,7,8-tétrahydro[1,2,4]triazolo[4,3- a]pyridin-3(2H)-ones et 2,5,6,7-tétrahydro-3H-pyrrolo[2,1 -c][1,2,4]triazol-3-ones substituées, leurs procédés de production, leur utilisation seuls ou en association pour le traitement et/ou la prophylaxie de maladies, ainsi que leur utilisation pour la production de médicaments servant au traitement et/ou à la prophylaxie de maladies, notamment au traitement et/ou à la prophylaxie de maladies pulmonaires.
Bibliography:Application Number: CA20173023383